Related Experiment Video
Updated: Aug 12, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
The diagnosis and management of hereditary spherocytosis
1Royal Liverpool Children's Hospital, Liverpool, UK.
Insights
Hereditary spherocytosis (HS) is a common blood disorder, often diagnosed easily. Management varies from watchful waiting for mild cases to splenectomy for severe hereditary spherocytosis.
Area of Science:
- Hematology
- Genetics
- Pediatric Medicine
Background:
- Hereditary spherocytosis (HS) is a prevalent genetic hemolytic anemia.
- Most Caucasian individuals present with mild to moderate disease.
- Diagnosis is typically clinical, but atypical cases require advanced testing.
Purpose of the Study:
- To outline the diagnostic approaches for hereditary spherocytosis.
- To detail management strategies based on disease severity.
- To emphasize the importance of differentiating HS from conditions like stomatocytosis.
Main Methods:
- Clinical presentation and family history review.
- Laboratory tests including membrane protein analysis.
- Molecular genetics for complex cases.
- Surgical intervention considerations, specifically splenectomy.
Main Results:
- Mild HS managed conservatively without splenectomy or folate supplements.
- Splenectomy benefits moderate to severe HS cases, recommended after age 6.
- Ruling out stomatocytosis is critical due to splenectomy contraindications.
Conclusions:
- Accurate diagnosis of hereditary spherocytosis is key for appropriate management.
- Splenectomy is a viable option for severe HS, with careful pre-operative counseling.
- Laparoscopic splenectomy offers benefits like reduced hospital stay and pain.
Abstract:
Hereditary spherocytosis (HS) is relatively common in Caucasian populations; most individuals have mild or only moderate disease. There is commonly a family history and a typical clinical and laboratory picture so that the diagnosis is usually easily made without additional laboratory tests. Atypical cases may require measurement of membrane proteins and molecular genetics to clarify the nature of the membrane disorder. It is particularly important to rule out stomatocytosis because splenectomy is contraindicated because of the thrombotic risk. Mild HS can be managed without folate supplements and does not require splenectomy. Moderately and severely affected individuals are likely to benefit from splenectomy, which should be performed after the age of 6 and with appropriate counselling about the risk of infection. In all cases careful dialogue between physician, child and the family is essential. Laparoscopic surgery can result in shorter hospital stay and less pain.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
iPS Cell Differentiation
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

